The Nazi Evil Behind Germany’s Wealthiest Companies

Supplying uniforms to the German empire, textile magnate Gunther Quandt made millions during World War I.  Shortly after, when electrification was booming worldwide, he gained control of one of the world’s largest battery-makers.  He soon acquired one of Germany’s primary arms and ammo manufacturers.  This was just the beginning.  He went on to gain stupendous wealth and power through deals with the Nazis.  The story of Quandt, as told in David de Jong’s Nazi Billionaires: The Dark History of Germany’s Wealthiest Dynasties, evokes awe and dread.  For it is about soulless profiteering and participation without any qualms in the enslavement and massacre of millions of Jews.

It is well known that many dynastic German companies owe their standing to their complicity — even willful participation — in Nazi evil.  De Jong investigated five key industrialists who funded Adolf Hitler’s rise to power, were complicit in horrendous crimes, and reaped billions from that cold-blooded investment: Quandt, automaker Ferdinand Porsche, Richard Kaselowsky of the Dr. Oetker Group, financier August von Finck, and industrialist Frederick Flick.  His book details their deals and post-war cover-ups.  It also tells how they were virtually absolved of all wrongdoing because the West needed Germany as a bulwark against Russia and its East European satellites.

Keep reading

BlackRock and Vanguard are taking over centralized food production technologies and will have near-total control over the future food supply in America

Many people are still blissfully unaware of what has happened, but the global food supply has been largely taken over by the oligarchs, including financial giants BlackRock and Vanguard.

It turns out that BlackRock and Vanguard have been gradually gobbling up ownership of the means of production, and now intend to lord it over the masses by centralizing all food production technologies in the United States and enslaving everyone under their control.

The top three shareholders of CD Industries Holdings, the world’s largest fertilizer company, include both BlackRock and Vanguard. BlackRock and Vanguard are also the top shareholders in Union Pacific, the railroad giant that moves fertilizer and other agriculture inputs all across the country.

The world’s top 10 food companies are also largely owned by both BlackRock and Vanguard. These include Nestlé, PepsiCo, General Mills, Kellogg’s, Associated British Foods, Mondel?z, Mars, Danone, Unilever, and Coca-Cola.

“What happens when they control all of the seeds, produce, and meat too?” asks Corey’s Digs.

“What happens when produce and meat are all grown inside secured facilities after a gene splice or inside a petri dish, and farmland becomes dormant due to overreaching regulations, lack of supplies, and manufactured inflation?”

Keep reading

Motion Picture Association wants online ID checks to curb piracy

The Motion Picture Association (MPA) wants stricter online identity checks to be part of the new trade agreement between the US and countries in the Indo-Pacific region. The film industry group also wants offline enforcement tools to apply online.

MPA is concerned that website operators use unconfirmed identities when signing up for Infrastructure as a Service (IaaS) services. There are multiple types of IaaS services, but MPA narrows it down to CDNs, proxy services, domain registrars, and web hosting. Companies providing these services enable piracy by providing their services to piracy websites, MPA argues.

IaaS services providers are currently not legally obligated to carry out identity checks. MPA believes the new trade agreement between the US and Indo-Pacific region is an opportunity to introduce such a requirement, Torrent Freak reports.

Keep reading

The illusion of Evidence-based Medicine

In 1990, a paradigm shift occurred in the development of new medicines and treatments. An idea so big, that it was supposed to encompass the whole of medicine. It was to start initially at the level of pre-clinical and clinical trials and work all the way through the system to the care and management of individual patients. This new concept for how medicine would be developed and conducted is called evidence-based medicine (EBM). Evidence-based medicine was to provide a more rigorous foundation for medicine, one based on science and the scientific method. Truly, this was to be a revolution in medicine – a non-biased way of conducting medical research and treating patients.

Evidence-based medicine

Evidence-based medicine is “the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients.” The aim of EBM is to integrate the experience of the clinician, the values of the patient, and the best available scientific information to guide decision-making about clinical management.

So, what the hell happened?

There is a big flaw in the logic of evidence-based medicine as the basis for the practice of medicine as we know it, a practice based on science; one that determines care down to the level of the individual patient. This flaw is nestled in the heart and soul of evidence-based medicine, which (as we have seen over the last two years) is not free of politics. It is naive to think that data and the process of licensure of new drugs is free from bias and conflicts of interest. In fact, this couldn’t be any farther from the truth. The COVID-19 crisis of 2020 to 2022 has exposed for all to see how evidence based medicine has been corrupted by the governments, hospitalists, academia, big pharma, tech and social media. They have leveraged the processes and rationale of evidence-based medicine to corrupt the entire medical enterprise.

Evidence based medicine depends on data. For the most part, the data gathering and analysis process is conducted by and for the pharmaceutical industry, then reported by senior academics. The problem, as laid out in an editorial in the British Medical Journal is as follows:

The release into the public domain of previously confidential pharmaceutical industry documents has given the medical community valuable insight into the degree to which industry sponsored clinical trials are misrepresented. Until this problem is corrected, evidence based medicine will remain an illusion.

This ideal of the integrity of data and the scientific process is corrupted as long as financial (and governments) interests trump the common good.

Keep reading